Accuracy of Preoperative Endorectal MRI in Predicting Extracapsular Extension and Influence on Neurovascular Bundle Sparing in Radical Prostatectomy
Overview
Authors
Affiliations
Purpose: To evaluate the accuracy of presurgical endorectal MRI (eMRI) for local staging before radical prostatectomy (RP) and its influence on neurovascular bundle (NVB) resection during radical prostatectomy.
Patients And Methods: A total of 385 patients with histologically proven prostate cancer (PCa) have been included in this retrospective study between 2004 and 2008. All patients underwent preoperative eMRI at 1.5 T before open RP. Staging results by eMRI were compared with the histopathological findings. The presence of positive surgical margins and extent of nerve-sparing procedure were evaluated. Subgroup analysis of low-risk group and intermediate to high-risk group based on D'Amico criteria was conducted.
Results: In 294 (76.4%) patients, pathological stage was correctly predicted, 69 patients (17.9%) were understaged and 22 (5.7%) overstaged. Overall sensitivity, specificity, negative and positive predictive value for predicting extracapsular extension (ECE) were 41.5, 91.8, 78.0 and 69.0%, respectively. One hundred and fifty-two (48.4%) of the patients classified as stage cT2 by eMRI underwent bilateral NVB sparing, whereas 14 (19.7%) patients with reported ECE underwent bilateral NVB sparing (P < 0.01). Overall positive surgical margin rate was 14.8%. Sensitivity of predicting ECE and positive predictive value were lower in the low-risk group than in the intermediate and high-risk group.
Conclusions: eMRI is effective in predicting extracapsular extension in an intermediate to high-risk group. Preoperative eMRI in patients with low-risk criteria is not recommended as a routine assessment modality. eMRI findings did appear to influence surgical strategy as patients with imaging findings suggesting >cT2 disease were less likely to undergo NVB sparing.
Lin Y, Belue M, Yilmaz E, Law Y, Merriman K, Phelps T Abdom Radiol (NY). 2024; 49(8):2891-2901.
PMID: 38958754 PMC: 11300622. DOI: 10.1007/s00261-024-04468-5.
Predictors of Extraprostatic Extension in Patients with Prostate Cancer.
Kim S, Cho S, Kim W, Kim H, Park J, Kim G J Clin Med. 2023; 12(16).
PMID: 37629363 PMC: 10455404. DOI: 10.3390/jcm12165321.
Wang Y, Wu Y, Zhu M, Tian M, Liu L, Yin L Diagnostics (Basel). 2023; 13(15).
PMID: 37568860 PMC: 10417235. DOI: 10.3390/diagnostics13152497.
Radiomics and Prostate MRI: Current Role and Future Applications.
Cutaia G, La Tona G, Comelli A, Vernuccio F, Agnello F, Gagliardo C J Imaging. 2021; 7(2).
PMID: 34460633 PMC: 8321264. DOI: 10.3390/jimaging7020034.
Griffiths L, Kotamarti S, Mikhail D, Sarcona J, Rastinehad A, Villani R Can Urol Assoc J. 2021; 15(8):261-266.
PMID: 33410741 PMC: 8418253. DOI: 10.5489/cuaj.6909.